| Comprehensive genomic profiles of small cell lung cancer J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ... Nature 524 (7563), 47-53, 2015 | 1959 | 2015 |
| KIF5B-RET fusions in lung adenocarcinoma T Kohno, H Ichikawa, Y Totoki, K Yasuda, M Hiramoto, T Nammo, ... Nature medicine 18 (3), 375-377, 2012 | 986 | 2012 |
| Circulating exosomal microRNAs as biomarkers of colon cancer H Ogata-Kawata, M Izumiya, D Kurioka, Y Honma, Y Yamada, K Furuta, ... PloS one 9 (4), e92921, 2014 | 879 | 2014 |
| Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas H Okayama, T Kohno, Y Ishii, Y Shimada, K Shiraishi, R Iwakawa, ... Cancer research 72 (1), 100-111, 2012 | 776 | 2012 |
| Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA T Kohno, K Shinmura, M Tosaka, M Tani, SR Kim, H Sugimura, T Nohmi, ... Oncogene 16 (25), 3219-3225, 1998 | 574 | 1998 |
| hOGG1 Ser326Cys Polymorphism and Lung Cancer Susceptibility H Sugimura, T Kohno, K Wakai, K Nagura, K Genka, H Igarashi, BJ Morris, ... Cancer Epidemiology Biomarkers & Prevention 8 (8), 669-674, 1999 | 357 | 1999 |
| Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases K Ishigaki, M Akiyama, M Kanai, A Takahashi, E Kawakami, H Sugishita, ... Nature genetics 52 (7), 669-679, 2020 | 343 | 2020 |
| Prevalence and specificity of LKB1 genetic alterations in lung cancers S Matsumoto, R Iwakawa, K Takahashi, T Kohno, Y Nakanishi, Y Matsuno, ... Oncogene 26 (40), 5911-5918, 2007 | 339 | 2007 |
| Comprehensive histologic analysis of ALK-rearranged lung carcinomas A Yoshida, K Tsuta, H Nakamura, T Kohno, F Takahashi, H Asamura, ... The American journal of surgical pathology 35 (8), 1226-1234, 2011 | 332 | 2011 |
| Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage K Arai, K Morishita, K Shinmura, T Kohno, SR Kim, T Nohmi, M Taniwaki, ... Oncogene 14 (23), 2857-2861, 1997 | 332 | 1997 |
| Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Q Lan, CA Hsiung, K Matsuo, YC Hong, A Seow, Z Wang, HD Hosgood III, ... Nature genetics 44 (12), 1330-1335, 2012 | 326 | 2012 |
| Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors H Ogiwara, A Ui, A Otsuka, H Satoh, I Yokomi, S Nakajima, A Yasui, ... Oncogene 30 (18), 2135-2146, 2011 | 313 | 2011 |
| Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial K Yoh, T Seto, M Satouchi, M Nishio, N Yamamoto, H Murakami, ... The Lancet Respiratory Medicine 5 (1), 42-50, 2017 | 309 | 2017 |
| Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: a hospital‐based study K Sunami, H Ichikawa, T Kubo, M Kato, Y Fujiwara, A Shimomura, ... Cancer science 110 (4), 1480-1490, 2019 | 302 | 2019 |
| A synthetic lethality–based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1 T Oike, H Ogiwara, Y Tominaga, K Ito, O Ando, K Tsuta, T Mizukami, ... Cancer research 73 (17), 5508-5518, 2013 | 288 | 2013 |
| Frequent BRG1/SMARCA4–inactivating mutations in human lung cancer cell lines PP Medina, OA Romero, T Kohno, LM Montuenga, R Pio, J Yokota, ... Human mutation 29 (5), 617-622, 2008 | 286 | 2008 |
| Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer T Kohno, T Nakaoku, K Tsuta, K Tsuchihara, S Matsumoto, K Yoh, K Goto Translational lung cancer research 4 (2), 156, 2015 | 278 | 2015 |
| Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement T Shimura, M Yamamoto, S Kano, A Kagase, A Kodama, Y Koyama, ... Circulation 135 (21), 2013-2024, 2017 | 253 | 2017 |
| The association of microRNA expression with prognosis and progression in early-stage, non–small cell lung adenocarcinoma: a retrospective analysis of three cohorts M Saito, AJ Schetter, S Mollerup, T Kohno, V Skaug, ED Bowman, ... Clinical cancer research 17 (7), 1875-1882, 2011 | 237 | 2011 |
| Targeting the vulnerability of glutathione metabolism in ARID1A-deficient cancers H Ogiwara, K Takahashi, M Sasaki, T Kuroda, H Yoshida, R Watanabe, ... Cancer cell 35 (2), 177-190. e8, 2019 | 226 | 2019 |
